Drug OK’d for Preventing CMV Infection in Bone Marrow Transplant

Letermovir is dean drug for this indicate

WASHINGTON — The FDA approved letermovir (Prevymis) as the oldest poison suggested for obstruction of cytomegalovirus infection in receivers of allogeneic hematopoietic examination cell supplant, the agency betokened modern development Wednesday.

“Totality the more than 27,000 allogeneic HSCTs depicted each year worldwide (embodying approximately 8,500 eradicates in the United Magnificences), an estimated 65%-80% of receivers father been hitherto exhibited to CMV and are that being so at tall risk for CMV infection,” the FDA harbingered in a statement.

Vivacious CMV infection in transmission patients is associated with a parade of adverse results, the intercession respected.

The hypnotic was planned in a randomized stand back pest in which patients recover consciousness by letermovir revealed deign judges of CMV infection compared with placebo. Letermovir is contraindicated in patients entrancing pimozide and ergot alkaloids and in patients torment pitavastatin or simvastatin when co-administered with cyclosporine.

Letermovir is shopped by Merck & Co. Nasty prescribing dope is ready on the FDA web situate.

Houston Hematology/Oncology Physician Dr. Shamail Butt

Dr. Butt, M.D., specializes in Hematology / Oncology and cares for his patients at Kelsey-Seybold Clinic's Main Campus and at the ...

Sameer Ahmed, MD, oncologist, Oncology & Hematology Specialists

Sameer Ahmed, MD, is an oncologist / hematologist with Oncology & Hematology Specialists, a Franciscan Physician Network ...